Cited by 920Computational Drug Discovery MethodsMachine Learning in Materials ScienceChemical Synthesis and Analysis

The DOI matches its Crossref record; 251 of the 252 references it cites were found in a registry or an index.

Automating drug discovery

Schneider, Gisbert·2018·Nature Reviews Drug Discovery

DOI 10.1038/nrd.2017.232

Open this paper in CoChat — free account

Abstract

Small-molecule drug discovery can be viewed as a challenging multidimensional problem in which various characteristics of compounds - including efficacy, pharmacokinetics and safety - need to be optimized in parallel to provide drug candidates. Recent advances in areas such as microfluidics-assisted chemical synthesis and biological testing, as well as artificial intelligence systems that improve a design hypothesis through feedback analysis, are now providing a basis for the introduction of greater automation into aspects of this process. This could potentially accelerate time frames for compound discovery and optimization and enable more effective searches of chemical space. However, such approaches also raise considerable conceptual, technical and organizational challenges, as well as scepticism about the current hype around them. This article aims to identify the approaches and technologies that could be implemented robustly by medicinal chemists in the near future and to critically analyse the opportunities and challenges for their more widespread application.

Integrity signals

Registry

Crossref · 10.1038/nrd.2017.232

Cites

251 of 251 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Deep learning
LeCun, Y., Bengio, Y., & Hinton, G. (2015) · Nature · doi:10.1038/nature14539 · Cited by 84,126
Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings 1PII of original article: S0169-409X(96)00423-1. The article was originally published in Advanced Drug Delivery Reviews 23 (1997) 3–25. 1
Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00129-0 · Cited by 18,139
A survey on deep learning in medical image analysis
Litjens, G., Kooi, T., Bejnordi, B. E., Setio, A. A. A., Ciompi, F., Ghafoorian, M., van der Laak, J. A. W. M., van Ginneken, B., & Sánchez, C. I. (2017) · Medical Image Analysis · doi:10.1016/j.media.2017.07.005 · Cited by 15,332
Solid Phase Peptide Synthesis. I. The Synthesis of a Tetrapeptide
Merrifield, R. B. (1963) · Journal of the American Chemical Society · doi:10.1021/ja00897a025 · Cited by 7,825
In-Datacenter Performance Analysis of a Tensor Processing Unit
Jouppi, N. P., Young, C., Patil, N., Patterson, D., Agrawal, G., Bajwa, R., Bates, S., Bhatia, S., Boden, N., Borchers, A., et al. (2017) · Proceedings of the 44th Annual International Symposium on Computer Architecture · doi:10.1145/3079856.3080246 · Cited by 4,537
Microfluidics: Fluid physics at the nanoliter scale
Squires, T. M., & Quake, S. R. (2005) · Reviews of Modern Physics · doi:10.1103/revmodphys.77.977 · Cited by 4,507
Distilling Free-Form Natural Laws from Experimental Data
Schmidt, M., & Lipson, H. (2009) · Science · doi:10.1126/science.1165893 · Cited by 3,327
The Medicinal Chemist’s Toolbox: An Analysis of Reactions Used in the Pursuit of Drug Candidates
Roughley, S. D., & Jordan, A. M. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm200187y · Cited by 2,768
Target-Oriented and Diversity-Oriented Organic Synthesis in Drug Discovery
Schreiber, S. L. (2000) · Science · doi:10.1126/science.287.5460.1964 · Cited by 2,571
The influence of drug-like concepts on decision-making in medicinal chemistry
Leeson, P. D., & Springthorpe, B. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2445 · Cited by 2,403

Flagged first, then by citations

Show all 252 references

1 of the 252 references couldn’t be matched to a known paper.

Research works printed but not linked: 1

Sparkes, A. et al. Towards robot scientists for autonomous scientific discovery. Autom. Exp. 2, 1 (2010). · DOI

Sorted by citations

Items 301–400 of 920

Exploring the Artificial Intelligence and Its Impact in Pharmaceutical Sciences: Insights Toward the Horizons Where Technology Meets Tradition
Bharadwaj, S., Deepika, K., Kumar, A., Jaiswal, S., Miglani, S., Singh, D., Fartyal, P., Kumar, R., Singh, S., Singh, M. P., et al. (2024) · Chemical Biology & Drug Design · doi:10.1111/cbdd.14639 · Cited by 19
Active learning and Gaussian processes for the development of dissolution models: An AI-based data-efficient approach
Patel, R. A., Kesharwani, S. S., & Ibrahim, F. (2025) · Journal of Controlled Release · doi:10.1016/j.jconrel.2025.01.003 · Cited by 21
Fluorescence spectral shape analysis for nucleotide identification
Huang, Y., Li, Z., Risinger, A. L., Enslow, B. T., Zeman, C. J., Gong, J., Yang, Y., & Schanze, K. S. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1820713116 · Cited by 18
Discovery of New Small Molecule Hits as Hepatitis B Virus Capsid Assembly Modulators: Structure and Pharmacophore-Based Approaches
Senaweera, S., Du, H., Zhang, H., Kirby, K. A., Tedbury, P. R., Xie, J., Sarafianos, S. G., & Wang, Z. (2021) · Viruses · doi:10.3390/v13050770 · Cited by 18
“In accordance with the advancement of machine learning related to medicinal chemistry [22,23], d velopment of virtual compound libraries is also being carried out by numerous institutions and chemical vendors to ease the process of find ng hit compounds in a r pid and cost-effective manner and with an acceptable accur…”
Background
New imidazole-2-ones and their 2-thione analogues as anticancer agents and CAIX inhibitors: Synthesis, in silico ADME and molecular modeling studies
Ibrahim, S. A., AL-Mhyawi, S. R., & Atlam, F. M. (2023) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2023.106872 · Cited by 18
Future AI Will Most Likely Predict Antibody-Drug Conjugate Response in Oncology: A Review and Expert Opinion
Sobhani, N., D’Angelo, A., Pittacolo, M., Mondani, G., & Generali, D. (2024) · Cancers · doi:10.3390/cancers16173089 · Cited by 19
“Worth noting is that newly discovered drugs have been ranked based on efficacy values (IC 50 and binding affinity) through molecular simulations and ultimately via in vitro validation experiments [5,6].”
Background
De novo Molecular Design with Generative Long Short-term Memory
Grisoni, F., & Schneider, G. (2019) · CHIMIA International Journal for Chemistry · doi:10.2533/chimia.2019.1006 · Cited by 18
Self-citation
Photo RAFT Polymerization
Chapman, R., Jung, K., & Boyer, C. A. (2021) · Wiley eBooks · doi:10.1002/9783527821358.ch12 · Cited by 20
Current Drug Discovery
Hale, J. J. (2022) · Wiley eBooks · doi:10.1002/9781119627784.ch1 · Cited by 18
Advancements and Applications of Artificial Intelligence in Pharmaceutical Sciences: A Comprehensive Review
Mottaghi-Dastjerdi, N., & Soltany‐Rezaee‐Rad, M. (2024) · Iranian journal of pharmaceutical research · doi:10.5812/ijpr-150510 · Cited by 25
“Artificial intelligence's capabilities in analyzing large datasets and simulating biological processes can make drug discovery and development more efficient and cost-effective, potentially halving timelines and reducing costs by up to 40% by 2030 (110).”
Improving generalizability of drug–target binding prediction by pre-trained multi-view molecular representations
Ouyang, X., Feng, Y. X., Cui, C., Li, Y., Zhang, L., & Wang, H. (2024) · Bioinformatics · doi:10.1093/bioinformatics/btaf002 · Cited by 20
Pyrimidine derivatives as multifaceted antidiabetic agents: A comprehensive review of structure-activity relationships, mechanisms, and clinical potential
Marzouk, M. (2025) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2025.117859 · Cited by 17
Computational Landscape in Drug Discovery: From AI/ML Models to Translational Application
Sharma, D., Anabala, M., Jain, V. V., Shyam, M., Prince, S. E., & Muniyan, R. (2025) · Scientifica · doi:10.1155/sci5/1688637 · Cited by 17
“Te integration of AI with quantum computing, systems pharmacology, and generative models such as difusion and transformer-based architectures has the potential to yield novel drug-like molecules with enhanced precision [141, 142].”
The prospects of tumor chemosensitivity testing at the single-cell level
Yang, C., Yang, C., Yarden, Y., To, K. K. W., & Fu, L. (2020) · Drug Resistance Updates · doi:10.1016/j.drup.2020.100741 · Cited by 16
Trends in application of advancing computational approaches in GPCR ligand discovery
Zhu, S., Wu, M., Huang, Z., & An, J. (2021) · Experimental Biology and Medicine · doi:10.1177/1535370221993422 · Cited by 17
A multilevel generative framework with hierarchical self-contrasting for bias control and transparency in structure-based ligand design
Chan, L., Kumar, R., Verdonk, M. L., & Poelking, C. R. (2022) · Nature Machine Intelligence · doi:10.1038/s42256-022-00564-7 · Cited by 21
Designing microplate layouts using artificial intelligence
Rodríguez, M. A. F., Puigvert, J. C., & Spjuth, O. (2023) · Artificial Intelligence in the Life Sciences · doi:10.1016/j.ailsci.2023.100073 · Cited by 17
Targeting Sirtuin 1 for therapeutic potential: Drug repurposing approach integrating docking and molecular dynamics simulations
Alrouji, M., Alhumaydhi, F. A., Alsayari, A., Sharaf, S. E., Shafi, S., Anwar, S., Shahwan, M. J., Atiya, A., & Shamsi, A. (2023) · PLoS ONE · doi:10.1371/journal.pone.0293185 · Cited by 17
“Historically, drug discovery has often been driven by the search for compounds with novel chemical structures and mechanisms of action [20].”
Background
Development of a novel representation of drug 3D structures and enhancement of the TSR-based method for probing drug and target interactions
Milon, T. I., Wang, Y., Fontenot, R. L., Khajouie, P., Villinger, F. J., Raghavan, V. V., & Xu, W. (2024) · Computational Biology and Chemistry · doi:10.1016/j.compbiolchem.2024.108117 · Cited by 18
Perspectives on the use of machine learning for ADME prediction at AstraZeneca
Gawehn, E., Greene, N., Miljković, F. N., Obrezanova, O., Subramanian, V., Trapotsi, M., & Winiwarter, S. (2024) · Xenobiotica · doi:10.1080/00498254.2024.2352598 · Cited by 18
“…various forms of machine learning (Ml) methods into the drug development process that have transformed how drugs are developed in more recent times (Schneider 2018; Jiménez-luna et al. 2021) and have contributed to the increased productivity of research and development at AstraZeneca (Morgan et…”
Rare Disease Policy in High-Income Countries: An Overview of Achievements, Challenges, and Solutions
Gentilini, A., Neez, E., & Wong‐Rieger, D. (2025) · Value in Health · doi:10.1016/j.jval.2024.12.009 · Cited by 17
In silico discovery and biological validation of ligands of FAD synthase, a promising new antimicrobial target
Lans, I., Anoz‐Carbonell, E., Palacio‐Rodríguez, K., Aínsa, J. A., Medina, M., & Cossio, P. (2020) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1007898 · Cited by 17
“, active compounds found) and reduce the false negatives 12 in high-throughput compound screening [2, 3, 6–12].”
Background
Mapping biologically active chemical space to accelerate drug discovery
Sittampalam, G. S., Rudnicki, D. D., Tagle, D. A., Simeonov, A. M., & Austin, C. P. (2018) · Nature Reviews Drug Discovery · doi:10.1038/d41573-018-00007-2 · Cited by 16
Bridging the gap between target-based and phenotypic-based drug discovery
Calado, C. R. C. (2024) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2024.2355330 · Cited by 19
“These systems associated with automation and microfluidic assays [54,55] can strongly promote target discovery and target validation (Table 1) and develop more efficient phenotypic assays.”
Background
Simple User‐Friendly Reaction Format
Nippa, D. F., Müller, A. T., Atz, K., Konrad, D. B., Grether, U., Martin, R. E., & Schneider, G. (2025) · Molecular Informatics · doi:10.1002/minf.202400361 · Cited by 17
Self-citation
Enhancing fluorescent probe design through multilayer interaction convolutional networks: advancing biosensing and bioimaging precision
Ma, G., Ding, Q., Zhang, Y., Zeng, X., Zhu, K., Chen, H., Zhang, W., Wang, Q., Huang, S., Gong, P., et al. (2025) · Chemical Science · doi:10.1039/d4sc08695c · Cited by 16
“18,19 20 – 22 In a pioneering study, Par et al. introduced a deep learning strategy for the expeditious and dependable prediction of optical and photophysical attributes of organic compounds.”
Machine Learning with Digital Microfluidics for Drug Discovery and Development
Momtahen, S., Al-Obaidy, F., & Mohammadi, F. A. (2019) · Conference proceedings - Canadian Conference on Electrical and Computer Engineering · doi:10.1109/ccece.2019.8861842 · Cited by 16
“The desired patterns can be generated for further chemical synthesis, analysis and testing [31].”
Background
A Validated “Pool and Split” Approach to Screening and Optimization of Copper-Catalyzed C–N Cross-Coupling Reactions
Steimbach, R. R., Kollmus, P., & Santagostino, M. (2020) · The Journal of Organic Chemistry · doi:10.1021/acs.joc.0c02392 · Cited by 16
Drug‐Target Interaction Prediction Based on Adversarial Bayesian Personalized Ranking
Ye, Y., Wen, Y., Zhang, Z., He, S., & Bo, X. (2021) · BioMed Research International · doi:10.1155/2021/6690154 · Cited by 16
“Due to the high cost of conducting animal experiments and clinical trials for a new drug [2], a large number of machine learning-based methods have been widely used in DTI prediction in recent years, and the cost of drug development has been greatly reduced through rapid screening of potential drug-target combinations…”
Background
Kinetic mechanisms of covalent inhibition
McWhirter, C. L. (2021) · Annual reports in medicinal chemistry · doi:10.1016/bs.armc.2020.11.001 · Cited by 18
Systematic risk identification and assessment using a new risk map in pharmaceutical R&D
Schuhmacher, A., Brieke, C., Gassmann, O., Hinder, M., & Hartl, D. (2021) · Drug Discovery Today · doi:10.1016/j.drudis.2021.06.015 · Cited by 17
A “Pool and Split” Approach to the Optimization of Challenging Pd-Catalyzed C–N Cross-Coupling Reactions
Fordham, J. M., Kollmus, P., Cavegn, M., Schneider, R., & Santagostino, M. (2022) · The Journal of Organic Chemistry · doi:10.1021/acs.joc.2c00104 · Cited by 16
Efficient Synthesis of a Schiff Base Copper(II) Complex Using a Microfluidic Device
Kobayashi, M., Akitsu, T., Furuya, M., Sekiguchi, T., Shoji, S., Tanii, T., & Tanaka, D. (2023) · Micromachines · doi:10.3390/mi14040890 · Cited by 16
Evaluation of Automated Sample Preparation for Mycotoxin Analysis in Foods
Zhang, K. (2020) · Journal of AOAC International · doi:10.1093/jaoacint/qsz044 · Cited by 15
Using the structural diversity of RNA: protein interfaces to selectively target RNA with small molecules in cells: methods and perspectives
Li, A., Bouhss, A., Clément, M., Bauvais, C., Taylor, J. P., Bollot, G., & Pastré, D. (2023) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2023.1298441 · Cited by 15
“…such as AlphaFold (Jumper et al., 2021; Varadi et al., 2022), predicting of drug properties (Noé et al., 2020; Paul et al., 2021), de novo drug design (Schneider, 2018; Paul et al., 2021), candidate drug prioritization (Li et al., 2020), and synthesis pathway generation (Noé et al., 2020).”
Background
Microbial bioactive compounds from oleaginous yeast culture: insights into molecular docking interactions and toxicity prediction
Ayadi, I., Akermi, S., Louati, M., Gargouri, A. F., Mellouli, L., & Guerfali, M. (2024) · Biomass Conversion and Biorefinery · doi:10.1007/s13399-024-05516-2 · Cited by 15
“However, it is still considered a challenging task due to the involvement of multiple regulatory frameworks governing animal testing and the emergence of alternative testing platforms aided by artificial intelligence systems [81].”
Hit me with your best shot: Integrated hit discovery for the next generation of drug targets
Ashraf, S. N., Blackwell, J. H., Holdgate, G. A., Lucas, S. C. C., Solovyeva, A., Storer, R. I., & Whitehurst, B. C. (2024) · Drug Discovery Today · doi:10.1016/j.drudis.2024.104143 · Cited by 15
Unleashing the future: The revolutionary role of machine learning and artificial intelligence in drug discovery
Yadav, M. K., Dahiya, V., Tripathi, M. K., Chaturvedi, N., Rashmi, M., Ghosh, A., & Raj, V. S. (2024) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2024.177103 · Cited by 19
High-throughput microdroplet-based synthesis using automated array-to-array transfer
Huang, K., Chen, K., Morato, N. M., Sams, T. C., Dziekonski, E. T., & Cooks, R. G. (2025) · Chemical Science · doi:10.1039/d5sc00638d · Cited by 15
Combinatorial Synthesis of Peptoid Arrays via Laser‐Based Stacking of Multiple Polymer Nanolayers
Mattes, D. S., Streit, B., Bhandari, D. R., Greifenstein, J., Foertsch, T. C., Münch, S. W., Ridder, B., von Bojničić‐Kninski, C., Nesterov‐Mueller, A., Spengler, B., et al. (2018) · Macromolecular Rapid Communications · doi:10.1002/marc.201800533 · Cited by 15
Creating a Virtual Assistant for Medicinal Chemistry
Vidler, L. R., & Baumgartner, M. P. (2019) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.9b00151 · Cited by 15
Repurposing Existing Molecular Machines through Accurate Regulation of Cooperative Motions
Fu, H., Chipot, C. J., Cai, W., & Shao, X. (2020) · The Journal of Physical Chemistry Letters · doi:10.1021/acs.jpclett.0c03444 · Cited by 15
EFMC: Trends in Medicinal Chemistry and Chemical Biology
Auberson, Y. P., Arimondo, P. B., Duca, M., Essig, S., Grether, U., Rufer, A. C., Sbardella, G., Schopfer, U., Torrens, A., van der Stelt, M., et al. (2023) · ChemBioChem · doi:10.1002/cbic.202200690 · Cited by 16
Deep learning for molecular generation and optimization - a review of the state of the artPreprint
Elton, D. C., Boukouvalas, Z., Fuge, M., & Chung, P. W. (2019) · arXiv (Cornell University) · Cited by 15
Digital Transformation in the Pharmaceutical and Biotech Industry: Challenges and Research Directions
Subha, S., Shanmugathai, M., Prasanth, A., Sree Varagi, S., & Dhanashree, V. (2024) · Wiley eBooks · doi:10.1002/9781394195336.ch13 · Cited by 16
Advancing predictive modeling in computational chemistry through quantum chemistry, molecular mechanics, and machine learning
Rowaiye, A. B., Folarin, A. A., Akingbade, T. O., Okoli, J. C., Rowaiye, O. I., Folorunso, T. R., & Bur, D. (2025) · Discover Chemistry. · doi:10.1007/s44371-025-00363-0 · Cited by 16
“In parallel, community databases—including the Materials Project [134], NOMAD [135], and the Open Catalyst Project [29], have dramatically expanded access to millions of quantum-mechanical calculations across chemical and materials spaces.”
Artificial Intelligence in Drug Discovery: Integrative Advances From Data to Therapeutic Innovation
Mehran, M. J., Mohammadzadeh, S., Bolideei, M., Barzigar, R., Haider, K. H., Jadgal, N., & Bahrami, Y. (2026) · Drug Development Research · doi:10.1002/ddr.70229 · Cited by 14
Alternative methods go green! Green toxicology as a sustainable approach for assessing chemical safety and designing safer chemicals
Maertens, A., Luechtefeld, T. H., Knight, J., & Härtung, T. (2024) · ALTEX · doi:10.14573/altex.2312291 · Cited by 25
“– Integration of robotics with AI for automated high-throughput toxicity screening and drug discovery (Schneider, 2018).”
Background
Integrating clinical pharmacology and artificial intelligence: potential benefits, challenges, and role of clinical pharmacologists
Singh, H., Nim, D. K., Randhawa, A. S., & Ahluwalia, S. (2024) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2024.2317963 · Cited by 16
“AI technologies may significantly impact the drug discovery process by enabling researchers to analyze vast amounts of data, identify potential drug targets, and predict drug candidates with higher accuracy and efficiency [33].”
Background
Navigating the future: Microfluidics charting new routes in drug delivery
Mohammadi, M., Qadir, S. A., Faraj, A. M., Shareef, O. H., Mahmoodi, H., Mahmoudi, F., & Moradi, S. (2024) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2024.124142 · Cited by 14
Droplet-based microfluidics: an efficient high-throughput portable system for cell encapsulation
Dortaj, H., Amani, A. M., Tayebi, L., Azarpira, N., Toudeshkchouei, M. G., Hassanpour-Dehnavi, A., Karami, N., Abbasi, M., Najafian-Najafabadi, A., Behjani, Z. Z., et al. (2024) · Journal of Microencapsulation · doi:10.1080/02652048.2024.2382744 · Cited by 10
“Safely expanding of new pharma-ceuticals based on cell-based models and animals requires assessing drug toxicity (Schneider 2018).”
Closed-Loop Navigation of a Kinetic Zone Diagram for Redox-Mediated Electrocatalysis Using Bayesian Optimization, a Digital Twin, and Automated Electrochemistry
Pence, M. A., Hazen, G., & Rodríguez‐López, J. (2025) · Analytical Chemistry · doi:10.1021/acs.analchem.5c00099 · Cited by 15
“This paradigm has been applied to a myriad of problems in fields such as organic synthesis 14–18 , materials development 19–23 , drug discovery 24,25 , and more.”
Advancing automation in Compound Management: a novel industrial process underpinning drug discovery
Green, C. P., Spencer, P. A., & Sarda, S. (2020) · Drug Discovery Today · doi:10.1016/j.drudis.2020.09.032 · Cited by 14
The Rocky Road to a Digital Lab
Sagmeister, P., Williams, J. D., & Kappe, C. O. (2023) · CHIMIA International Journal for Chemistry · doi:10.2533/chimia.2023.300 · Cited by 14
Assessing drug response in engineered brain microenvironments
Tate, K. M., & Munson, J. M. (2019) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2019.04.027 · Cited by 14
“However, these systems are not readily affordable to all labs and are limited currently by availability of probes and primary compatibility with commercially available reagents (Schneider, 2018).”
Background
Artificial intelligence and infectious diseases: Scope and perspectives
Abbara, S., Crabol, Y., de Bouillé, J. G., Dinh, A., & Morquin, D. (2025) · Infectious Diseases Now · doi:10.1016/j.idnow.2025.105131 · Cited by 16
Simultaneous reaction- and analytical model building using dynamic flow experiments to accelerate process development
Sagmeister, P., Melnizky, L., Williams, J. D., & Kappe, C. O. (2024) · Chemical Science · doi:10.1039/d4sc01703j · Cited by 14
Applications, Challenges, and Future Perspectives of Artificial Intelligence in Psychopharmacology, Psychological Disorders and Physiological Psychology: A Comprehensive Review
Salemi, M. H., Foroozandeh, E., & Ashkzari, M. K. (2025) · Journal of Pharmacy And Bioallied Sciences · doi:10.4103/jpbs.jpbs_1765_24 · Cited by 13
“[13] Collaborative efforts between academia and industry address challenges in targeting new biological pathways and improving outcomes at preclinical and clinical stages.”
Structural Insight into the Binding Mode of FXR and GPBAR1 Modulators
Leva, F. S. D., Marino, D. D., & Limongelli, V. (2019) · Handbook of experimental pharmacology · doi:10.1007/164_2019_234 · Cited by 13
Correction: Exploration of flow reaction conditions using machine-learning for enantioselective organocatalyzed Rauhut–Currier and [3+2] annulation sequence
Kondo, M., Wathsala, H. D. P., Sako, M., Hanatani, Y., Ishikawa, K., Hara, S., Takaai, T., Washio, T., Takizawa, S., & Sasai, H. (2020) · Chemical Communications · doi:10.1039/d0cc90423f · Cited by 13
Computational genome engineering through AI-CRISPR-precision medicine integration in modern therapeutics
Agboola, O. E., Agboola, S. S., Odeghe, O. B., Olaiya, O. E., Ayinla, Z. A., Akinsanya, P. O., Ilesanmi, O. S., Kehinde, I. O., Adegbuyi, A. T., Kolawole, O. A., et al. (2025) · Annales Pharmaceutiques Françaises · doi:10.1016/j.pharma.2025.08.001 · Cited by 14
CKDTA: A chemical knowledge-enhanced framework for drug–target affinity prediction
Zhao, X., Guo, Y., Wang, B., & Li, W. (2025) · Journal of Computational Science · doi:10.1016/j.jocs.2025.102706 · Cited by 12
Organ‐on‐a‐Chip Technology and Global Multi‐Omics: Current Applications and Future Directions
Cao, X., Xia, C., Li, C., Deng, S., Cao, J., Yang, H., Wang, S., & Chen, P. (2026) · MedComm · doi:10.1002/mco2.70603 · Cited by 13
An Automated High-Throughput Screening (HTS) Spotter for 3D Tumor Spheroid Formation
Jeong, M., Kim, I.-H., Park, K., Ku, B., Lee, D. W., Park, K. R., Jeon, S. Y., & Kim, J. E. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24021006 · Cited by 12
Enantioselective construction of dihydropyranone-fused indoles by [3 + 3] annulation of in situ -derived indolin-3-ones and unsaturated carboxylic esters
Wang, H., Zhang, Q., Shuai, X., Wang, G., Huang, X., Chen, X., & Zhang, J. (2023) · Organic Chemistry Frontiers · doi:10.1039/d3qo00377a · Cited by 12
Artificial Intelligence (AI): It?s Role in Drug Discovery and Novel Drug Delivery System
Hujuri, C. D. L. (2024) · International Journal of Science and Research (IJSR) · doi:10.21275/sr24219203948 · Cited by 12
Late-Stage C( sp 2 )–C( sp 3 ) Diversification via Nickel Oxidative Addition Complexes
Odena, C., Santiago, T. G., Linares, M. L., Castellanos-Blanco, N. Y., McGuire, R. T., Chaves‐Arquero, B., Alonso, J. M., Diéguez-Vázquez, A., Tan, E. H. L., Alcázar, J., et al. (2024) · Journal of the American Chemical Society · doi:10.1021/jacs.4c08404 · Cited by 12
Data Science Driven Drug Repurposing for Metabolic Disorders
Nagamani, S., Sahoo, R., Muneeswaran, G., & Sastry, G. N. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-816125-8.00007-9 · Cited by 13
Activity‐Directed Synthesis: A Flexible Approach for Lead Generation
Karageorgis, G., Liver, S., & Nelson, A. S. (2020) · ChemMedChem · doi:10.1002/cmdc.202000524 · Cited by 12
Acyl(imidoyl)ketenes: Reactive Bidentate Oxa/Aza-Dienes for Organic Synthesis
Lystsova, E. A., Khramtsova, E. E., & Maslivets, A. N. (2021) · Symmetry · doi:10.3390/sym13081509 · Cited by 12
“After that, intermediate E′ underwent a [1,3]-Cl shift via the transition state TS3 to afford compound F′, the model of compounds 9.”
BackgroundInfluential
CoM-polynomial and topological coindices of hyaluronic acid conjugates
Kirmani, S. A. K., & Ali, P. (2022) · Arabian Journal of Chemistry · doi:10.1016/j.arabjc.2022.103911 · Cited by 12
Current trends in natural products for the treatment and management of dementia: Computational to clinical studies
Singla, R. K., Joon, S., Sinha, B., Kamal, M. A., Simal‐Gándara, J., Xiao, J., & Shen, B. (2023) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2023.105106 · Cited by 14
Autonome Entdeckung in den chemischen Wissenschaften, Teil I: Fortschritt
Coley, C. W., Eyke, N. S., & Jensen, K. F. (2019) · Angewandte Chemie · doi:10.1002/ange.201909987 · Cited by 12
Real-time monitoring the efficacy of 7-hydroxycoumarin to cells cultured on microfluidics in different extracellular pH environments by chip-mass spectrometry
Han, S., Zhang, P., Lin, H., Li, H., Guo, Y., Xu, N., & Lin, J. (2022) · Talanta · doi:10.1016/j.talanta.2022.123331 · Cited by 12
Advances in the screening of antimicrobial compounds using electrochemical biosensors: is there room for nanomaterials?
Toyos‐Rodríguez, C., Valero‐Calvo, D., & de la Escosura‐Muñiz, A. (2022) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-022-04449-x · Cited by 12
“This is the case of artificial intelligence (AI), a resource deeply needed for going through the more than 1030 drug-like compounds that it is estimated that still could be discovered [40, 41].”
Background
Developments and challenges in hit progression within fragment-based drug discovery
Grosjean, H., & Biggin, P. C. (2026) · Nature Communications · doi:10.1038/s41467-026-68941-z · Cited by 15
“While autonomous and integrated closed-loop work ﬂ ows are yet to be fully implemented, they have the potential streamline molecular design, chemical synthesis, and biological testing within compressed timelines 162,163 .”
Microfluidic asymmetrical synthesis and chiral analysis
Кочетков, К. А., Bystrova, N. A., Pavlov, P. A., Oshchepkov, M., & Oshchepkov, A. S. (2022) · Journal of Industrial and Engineering Chemistry · doi:10.1016/j.jiec.2022.08.025 · Cited by 13
Artificial Intelligence Approaches in Drug Discovery: Towards the Laboratory of the Future
Frusciante, L., Visibelli, A., Geminiani, M., Santucci, A., & Spiga, O. (2022) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026622666221006140825 · Cited by 11
AI-driven microbial medicine development
Dharmani, K., Sinha, A., & Chaturvedi, N. (2024) · Methods in microbiology · doi:10.1016/bs.mim.2024.05.008 · Cited by 11
Targeting the GTPase RAN by liposome delivery for tackling cancer stemness-emanated therapeutic resistance
Wang, K., Zhu, S., Zhang, Y., Wang, Y., Bian, Z., Lu, Y., Shao, Q., Xiang, J., Xu, X., & Mo, R. (2024) · Journal of Controlled Release · doi:10.1016/j.jconrel.2024.09.007 · Cited by 10
Autonomous Nucleic Acid and Protein Nanocomputing Agents Engineered to Operate in Living Cells
Panigaj, M., Roy, T. B., Skelly, E., Chandler, M. R., Wang, J., Ekambaram, S., Bircsak, K. M., Dokholyan, N. V., & Afonin, K. A. (2025) · ACS Nano · doi:10.1021/acsnano.4c13663 · Cited by 13
Deciphering the landscape of allosteric glutaminase 1 inhibitors as anticancer agents
Vagaggini, C., D’Ursi, P., Poggialini, F., Fossa, P., Francesconi, V., Trombetti, G., Orro, A., Dreassi, E., Schenone, S., Tonelli, M., et al. (2025) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2025.108523 · Cited by 12
Automated PET-RAFT Polymerization toward Pharmaceutical Amorphous Solid Dispersion Development
Upadhya, R., Punia, A., Kanagala, M. J., Liu, L., Lamm, M. S., Rhodes, T. A., & Gormley, A. J. (2021) · ACS Applied Polymer Materials · doi:10.1021/acsapm.0c01376 · Cited by 11
Toward efficient generation, correction, and properties control of unique drug‐like structures
Druchok, M., Yarish, D., Gurbych, O., & Maksymenko, M. (2021) · Journal of Computational Chemistry · doi:10.1002/jcc.26494 · Cited by 11
Natural Products, the Fourth Industrial Revolution, and the Quintuple Helix
Daley, S.-K., & Cordell, G. A. (2021) · Natural Product Communications · doi:10.1177/1934578x211003029 · Cited by 11
Novel Fluorescence-Based High-Throughput FLIPR Assay Utilizing Membrane-Tethered Genetic Calcium Sensors to Identify T-Type Calcium Channel Modulators
Zhang, Y., Moran, S. P., Allen, A. S., Báez-Nieto, D., Xu, Q., Wang, L. A., Martenis, W. E., Sacher, J. R., Gale, J. P., Weïwer, M., et al. (2022) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.1c00233 · Cited by 11
Development of an Automated Platform for C(sp3)−C(sp3) Bond Formation via XAT Chemistry
Pijper, B., Abdiaj, I., Leonori, D., & Alcázar, J. (2022) · ChemCatChem · doi:10.1002/cctc.202201289 · Cited by 11
On-Demand Optimization of Colorimetric Gas Sensors Using a Knowledge-Aware Algorithm-Driven Robotic Experimental Platform
Ai, Z., Zhang, L., Chen, Y., Long, Y., Li, B., Dong, Q., Wang, Y., & Jiang, J. (2024) · ACS Sensors · doi:10.1021/acssensors.3c02043 · Cited by 11
Neural Networks in Drug Discovery: Current Insights from Medicinal Chemists
Xu, Y., Li, X., Yao, H., & Lin, K. (2019) · Future Medicinal Chemistry · doi:10.4155/fmc-2019-0118 · Cited by 13
The Future of Molecular Studies through the Lens of Large Language Models
Zhang, J., Fang, Y., Shao, X., Chen, H., Zhang, N., & Fan, X. (2024) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.3c01977 · Cited by 12
Transform Drug Discovery and Development With Generative Artificial Intelligence
Lavecchia, A. (2025) · Wiley eBooks · doi:10.1002/9781394280735.ch25 · Cited by 14
Expediting hit-to-lead progression in drug discovery through reaction prediction and multi-dimensional optimization
Nippa, D. F., Atz, K., Stenzhorn, Y., Müller, A. T., Tosstorff, A., Benz, J., Binch, H., Bürkler, M., Haider, A., Heer, D., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-66324-4 · Cited by 11
Self-citation
The pivotal role of artificial intelligence in enhancing experimental animal model research: A machine learning perspective
Ghosh, A., Choudhary, G. P., & Medhi, B. (2024) · Indian Journal of Pharmacology · doi:10.4103/ijp.ijp_81_24 · Cited by 9
“[12] The creation of alcohol‑preferring and apomorphine‑susceptible rat strains through selective breeding aimed to mimic alcohol use disorder and schizophrenia.”
Merged and alternating droplets generation in double T-junction microchannels using symmetrically inserted capillaries
Shen, F., Zhang, Y., Li, C., Pang, Y., & Liu, Z. (2024) · Microfluidics and Nanofluidics · doi:10.1007/s10404-024-02725-z · Cited by 10
“Microdroplet generation devices have a broad range of applications in chemical synthesis (Elvira et al. 2013), drug discovery (Schneider 2018), protein crystallization (Zheng et al. 2004a), and medical diagnosis and treatment (Srikanth et al. 2021).”
MSN-DTA: A multi-scale node adaptive graph neural network for interpretable drug-target binding affinity prediction
Wang, J., Ding, P., Zhu, Y., Gao, X., Yu, X., & Yu, B. (2025) · Knowledge-Based Systems · doi:10.1016/j.knosys.2025.113699 · Cited by 11
The tree-based pipeline optimization tool: Tackling biomedical research problems with genetic programming and automated machine learning
Hernandez, J. G., Saini, A. K., Ghosh, A., & Moore, J. H. (2025) · Patterns · doi:10.1016/j.patter.2025.101314 · Cited by 10
“3 Notable successes include advancements in precision medicine, 4,5 drug discovery, 6,7,8 and disease diagnosis.”
Current Challenges in the Pharmaceutical Industry and AI's Role in Addressing Them
Gauthaman, S. A., Kumar, S. S., Kamaldheen, R., Murugesan, K., Viswanathan, M. K., Devendran, H., & Muniasamy, A. (2025) · IGI Global eBooks · doi:10.4018/979-8-3373-2043-4.ch001 · Cited by 11
Nanoscale Direct-to-Biology Optimization of Cdk2 Inhibitors
Douthwaite, J. L., Houde, D. J., Pardo, E., Moran, M., Baird, J., Meyer, S. R., Mahjour, B. A., Zhao, Q., Larrow, J. F., Juang, Y.-P., et al. (2026) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5c03614 · Cited by 10
Advances in predictive chemistry enable a multi-scale rational design approach for biofuels with advantaged properties
Lockwood, K. S., Ahmed, S. F., Huq, N. A., Stutzman, S. C., Foust, T. D., & Labbe, N. J. (2022) · Sustainable Energy & Fuels · doi:10.1039/d2se00773h · Cited by 9
Machine learning‐assisted search for novel coagulants: When machine learning can be efficient even if data availability is low
Rovenchak, A. A., & Druchok, M. (2024) · Journal of Computational Chemistry · doi:10.1002/jcc.27292 · Cited by 9

Authors: Schneider, G.
Affiliations: ETH Zurich (CH)
Corresponding author: Schneider, Gisbert
ORCID: Schneider, Gisbert
Venue: Nature Reviews Drug Discovery
Publisher: Springer Science and Business Media LLC
Published: 2017-12-15
Volume: 17
Issue: 2
Pages: 97-113
ISSN: 1474-1776 (ISSN-L)
1474-1784
DOI: 10.1038/nrd.2017.232
OpenAlex: W2775714759
Cited by: 910
References: 252
Citations by year: 2026: 167 · 2025: 154 · 2024: 119 · 2023: 89 · 2022: 87 · 2021: 92 · 2020: 79 · 2019: 74 · 2018: 47 · 2017: 1
FWCI: 5.61
Type: journal article
Language: en
Open access: closed
Licence: www.springernature.com/gp/researchers/text-and-data-mining (tdm)
www.springernature.com/gp/researchers/text-and-data-mining (vor)
Locations: Nature Reviews Drug Discovery (publishedVersion)
PubMed (publishedVersion)
Funders: National Science Foundation
AstraZeneca
OPO-Stiftung
European Commission (HORIZON2020, 675555, 676434)
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (157190, 159737)
Horizon 2020 (676434)
Topics: Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
Physical Sciences › Materials Science › Materials Chemistry › Machine Learning in Materials Science
Physical Sciences › Chemistry › Organic Chemistry › Chemical Synthesis and Analysis
Keywords: small molecule drug discovery, artificial intelligence in drug design, compound optimization, chemical space exploration, medicinal chemistry, pharmacokinetics, drug safety
MeSH terms: Animals, Drug Industry, Pharmaceutical Preparations, Humans, Drug Discovery

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Automating drug discovery

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Citations

Cites

Cited by

Related

Metadata

Record

About these checks